Detalhe da pesquisa
1.
Mass Spectrometry-Based Assessment of M-protein in Peripheral Blood During Maintenance Therapy in Multiple Myeloma.
Blood
; 2024 May 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38713888
2.
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial.
Lancet Oncol
; 24(2): 139-150, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36642080
3.
Safety and efficacy of induction immunochemotherapy with rituximab, methotrexate, ifosfamide, and vincristine (R-MIV) in patients with primary CNS lymphoma including recent COVID-19 pandemic experience.
Br J Haematol
; 201(4): 663-672, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36762710
4.
Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: Subanalysis of the randomized phase 3 ATLAS trial.
Br J Haematol
; 203(5): 792-802, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37691005
5.
Therapeutic adherence and assessment of satisfaction patients with multiple myeloma treated with immunomodulatory drugs in a "real-world" study: Experiences of the Polish Myeloma Group.
J Oncol Pharm Pract
; : 10781552231203371, 2023 Sep 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37728209
6.
Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization.
Int J Mol Sci
; 24(10)2023 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37239846
7.
Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation-ineligible relapsed and refractory diffuse large B-cell lymphoma.
Br J Haematol
; 198(1): 73-81, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35362096
8.
Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival.
Int J Cancer
; 148(8): 1887-1894, 2021 04 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33152124
9.
Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients.
Int J Cancer
; 149(2): 327-336, 2021 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33675538
10.
Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients.
Br J Haematol
; 183(3): 375-384, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30079960
11.
Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients.
Br J Haematol
; 180(6): 831-839, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29315478
12.
Identification of miRSNPs associated with the risk of multiple myeloma.
Int J Cancer
; 140(3): 526-534, 2017 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27718532
13.
Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.
Am J Hematol
; 91(6): 575-80, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-26955792
14.
A Stepwise Screening Protocol for Multiple Myeloma.
J Clin Med
; 12(4)2023 Feb 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36835883
15.
High efficacy of intensive immunochemotherapy for primary mediastinal B-cell lymphoma with prolonged follow up.
Sci Rep
; 12(1): 10551, 2022 06 22.
Artigo
Inglês
| MEDLINE | ID: mdl-35732790
16.
A polygenic risk score for multiple myeloma risk prediction.
Eur J Hum Genet
; 30(4): 474-479, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34845334
17.
Bendamustine-Based Regimens as Salvage Therapy in Refractory/Relapsed Multiple Myeloma Patients: A Retrospective Real-Life Analysis by the Polish Myeloma Group.
J Clin Med
; 10(23)2021 Nov 24.
Artigo
Inglês
| MEDLINE | ID: mdl-34884206
18.
Genetically determined telomere length and multiple myeloma risk and outcome.
Blood Cancer J
; 11(4): 74, 2021 04 14.
Artigo
Inglês
| MEDLINE | ID: mdl-33854038
19.
Primary refractory multiple myeloma: a real-world experience with 85 cases.
Leuk Lymphoma
; 61(12): 2868-2875, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32623944
20.
Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium.
Leuk Lymphoma
; 61(3): 699-706, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31746254